Document Detail

Vasopressor and inotropic support in septic shock: an evidence-based review.
MedLine Citation:
PMID:  15542956     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: In 2003, critical care and infectious disease experts representing 11 international organizations developed management guidelines for vasopressor and inotropic support in septic shock that would be of practical use for the bedside clinician, under the auspices of the Surviving Sepsis Campaign, an international effort to increase awareness and to improve outcome in severe sepsis. DESIGN: The process included a modified Delphi method, a consensus conference, several subsequent smaller meetings of subgroups and key individuals, teleconferences, and electronic-based discussion among subgroups and among the entire committee. METHODS: The modified Delphi methodology used for grading recommendations built on a 2001 publication sponsored by the International Sepsis Forum. We undertook a systematic review of the literature graded along five levels to create recommendation grades from A to E, with A being the highest grade. Pediatric considerations to contrast adult and pediatric management are in the article by Parker et al. on p. S591. CONCLUSION: An arterial catheter should be placed as soon as possible in patients with septic shock. Vasopressors are indicated to maintain mean arterial pressure of <65 mm Hg, both during and following adequate fluid resuscitation. Norepinephrine or dopamine are the vasopressors of choice in the treatment of septic shock. Norepinephrine may be combined with dobutamine when cardiac output is being measured. Epinephrine, phenylephrine, and vasopressin are not recommended as first-line agents in the treatment of septic shock. Vasopressin may be considered for salvage therapy. Low-dose dopamine is not recommended for the purpose of renal protection. Dobutamine is recommended as the agent of choice to increase cardiac output but should not be used for the purpose of increasing cardiac output above physiologic levels.
Richard J Beale; Steven M Hollenberg; Jean-Louis Vincent; Joseph E Parrillo
Related Documents :
15542956 - Vasopressor and inotropic support in septic shock: an evidence-based review.
15216286 - Late ventricular fibrillation following successful resuscitation from postinfarction ca...
10146726 - Oxygen extraction in patients with sepsis and heart failure: another look at clinical s...
8241216 - Analysis of deaths after heart transplantation: the university of ottawa heart institut...
24493916 - Dual av nodal nonreentrant tachycardia resulting in inappropriate icd therapy in a pati...
21094356 - Predictors of death and occurrence of appropriate implantable defibrillator therapies i...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Critical care medicine     Volume:  32     ISSN:  0090-3493     ISO Abbreviation:  Crit. Care Med.     Publication Date:  2004 Nov 
Date Detail:
Created Date:  2004-11-15     Completed Date:  2005-01-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0355501     Medline TA:  Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S455-65     Citation Subset:  AIM; IM    
Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiotonic Agents / administration & dosage*
Consensus Development Conferences as Topic
Dobutamine / administration & dosage
Dopamine / administration & dosage
Evidence-Based Medicine
Norepinephrine / administration & dosage
Practice Guidelines as Topic
Shock, Septic / therapy*
Vasoconstrictor Agents / administration & dosage*
Reg. No./Substance:
0/Cardiotonic Agents; 0/Vasoconstrictor Agents; 34368-04-2/Dobutamine; 51-41-2/Norepinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fluid resuscitation in severe sepsis and septic shock: an evidence-based review.
Next Document:  Diagnosis of infection in sepsis: an evidence-based review.